FANCF Gene

FANCF Gene

Overview

FANCF (Fanconi Anemia Group F) is a critical gene located on chromosome 11p15 that encodes a scaffold protein essential for the Fanconi anemia (FA) DNA repair pathway. The gene is catalogued as NCBI Gene ID [2188](https://www.ncbi.nlm.nih.gov/gene/2188) and OMIM [607128](https://omim.org/entry/607128). FANCF serves as a central adaptor within the FA core complex, stabilizing protein-protein interactions required for interstrand crosslink (ICL) repair and maintaining genomic stability[@smogorzewska2005][@meetei2003].

The protein encoded by FANCF is [FANCF Protein](/proteins/fancf-protein), a 380-amino acid scaffold protein that plays a unique role in assembling and stabilizing the FA core complex. Unlike other FA proteins that have enzymatic functions, FANCF acts primarily as a molecular scaffold, bringing together multiple protein components to facilitate efficient DNA repair[@liu2007].

FANCF Gene

Overview

FANCF (Fanconi Anemia Group F) is a critical gene located on chromosome 11p15 that encodes a scaffold protein essential for the Fanconi anemia (FA) DNA repair pathway. The gene is catalogued as NCBI Gene ID [2188](https://www.ncbi.nlm.nih.gov/gene/2188) and OMIM [607128](https://omim.org/entry/607128). FANCF serves as a central adaptor within the FA core complex, stabilizing protein-protein interactions required for interstrand crosslink (ICL) repair and maintaining genomic stability[@smogorzewska2005][@meetei2003].

The protein encoded by FANCF is [FANCF Protein](/proteins/fancf-protein), a 380-amino acid scaffold protein that plays a unique role in assembling and stabilizing the FA core complex. Unlike other FA proteins that have enzymatic functions, FANCF acts primarily as a molecular scaffold, bringing together multiple protein components to facilitate efficient DNA repair[@liu2007].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">FANCF Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>FANCF</td></tr>
<tr><td><strong>Full Name</strong></td><td>Fanconi Anemia Group F</td></tr>
<tr><td><strong>Chromosome</strong></td><td>11p15</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[2188](https://www.ncbi.nlm.nih.gov/gene/2188)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[607128](https://omim.org/entry/607128)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>[ENSG00000163930](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163930)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NPI8](https://www.uniprot.org/uniprot/Q9NPI8)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>380 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~42 kDa</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Fanconi Anemia (type F), Breast Cancer, Ovarian Cancer</td></tr>
</table>
</div>

Gene Structure and Evolution

Genomic Organization

The FANCF gene is located on chromosome 11p15, a region frequently altered in various cancers. The gene consists of a single exon encoding the 380-amino acid FANCF protein, making it one of the simplest gene structures in the FA pathway. The gene is evolutionarily conserved, with orthologs identified in mammals, zebrafish, Drosophila, and Xenopus[@niraj2017].

Protein Domain Architecture

FANCF possesses a relatively simple domain structure optimized for protein-protein interactions:

The protein lacks enzymatic activity but contains multiple tetratricopeptide repeat (TPR) motifs that mediate protein-protein interactions[@thompson2020].

The Fanconi Anemia Pathway

Overview of FA DNA Repair

The Fanconi anemia pathway is a critical DNA repair network that specifically addresses interstrand crosslinks (ICLs)—severe DNA lesions that block DNA replication and transcription. ICLs can be caused by endogenous metabolic products (such as aldehydes), chemotherapeutic agents (cisplatin, mitomycin C), or environmental insults[@kottemann2013].

The FA pathway involves over 20 FANC proteins (FANCA-FANCV) that function in a coordinated manner:

FA Core Complex

The FA core complex is a multi-protein assembly consisting of:

• FANCA: Largest subunit, forms the core scaffold
• FANCB: Catalytic component
• FANCC: Stabilizes the complex
• FANCD2: Ubiquitination substrate (forms ID complex with FANCI)
• FANCE: Critical for FANCD2 monoubiquitination
• FANCF: Scaffold protein stabilizing the complex
• FANCG: Large subunit, multiple protein interactions
• FANCL: E3 ubiquitin ligase catalytic subunit
• FANCM: DNA translocase, senses ICLs

Biological Function

Scaffold Protein Function

FANCF's primary function is to serve as a molecular scaffold within the FA core complex:

Core Complex Assembly: FANCF directly interacts with FANCA and FANCG, stabilizing their association and facilitating proper assembly of the entire FA core complex. These interactions are essential for the stability and function of the complex[@liu2007].

Dimerization: FANCF forms homodimers that create a more stable scaffold platform. This dimerization is important for the cooperative assembly of the FA core complex[@joo2011].

Complex Stabilization: FANCF helps maintain the structural integrity of the FA core complex, particularly under conditions of cellular stress or replication stress.

Role in ICL Repair

While FANCF lacks enzymatic activity, it is essential for ICL repair:

Hematopoietic Stem Cell Function

The FA pathway, including FANCF, is particularly important in hematopoietic stem cells (HSCs):

• HSCs are highly sensitive to DNA damage
• The FA pathway protects HSCs from genotoxic stress
• Defects in any FA protein, including FANCF, lead to bone marrow failure[@sii2011]

Role in Disease

Fanconi Anemia Type F

Biallelic mutations in FANCF cause Fanconi anemia type F (FA-F), a subtype of Fanconi anemia characterized by:

• Congenital anomalies: Growth retardation, skeletal abnormalities, skin hyperpigmentation
• Bone marrow failure: Progressive pancytopenia, typically presenting in childhood
• Cancer predisposition: Markedly increased risk of acute myeloid leukemia and solid tumors
• Cellular sensitivity: Extreme sensitivity to DNA crosslinking agents

Cancer Susceptibility

Heterozygous carriers of FANCF variants and individuals with FANCF promoter methylation show increased cancer risk:

Breast and Ovarian Cancer: FANCF promoter methylation has been observed in sporadic breast and ovarian cancers, leading to reduced FA pathway activity and increased genomic instability[@chen2008][@castella2015].

Chemotherapy Resistance: Loss of FANCF expression in tumors can confer resistance to platinum-based chemotherapeutic agents, which induce DNA crosslinks similar to those repaired by the FA pathway[@taniguchi2002].

Epigenetic Silencing

FANCF is frequently epigenetically silenced in cancers:

• Promoter hypermethylation leads to transcriptional repression
• Epigenetic silencing occurs in ovarian, breast, cervical, and other cancers
• Associated with worse prognosis in some tumor types[@kim2012]

Role in Neurodegeneration

DNA Repair in Neurons

Neurons are particularly dependent on DNA repair mechanisms due to their post-mitotic state and high metabolic activity:

• Accumulated DNA damage over time contributes to neuronal dysfunction
• The FA pathway provides protection against endogenous DNA damage
• Impaired DNA repair can lead to neuronal death and neurodegeneration[@gurtan2013]

Neuronal Vulnerability

Several lines of evidence connect FANCF and neurodegeneration:

DNA Damage Accumulation: Defects in FANCF and other FA proteins lead to accumulated DNA damage in neurons, triggering apoptosis[@markkanen2015].

Aging: The FA pathway becomes less efficient with age, contributing to age-related neurodegeneration.

Neurodegenerative Diseases: Defects in DNA repair genes have been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions[@schmidt2015].

Brain-Specific Considerations

While FANCF mutations primarily cause hematological manifestations, the FA pathway is active in brain tissue:

• Neurons express FA pathway components
• The brain is particularly vulnerable to oxidative DNA damage
• Some FA patients exhibit neurological symptoms

Neuronal Stress Response

The FA pathway, including FANCF, plays a critical role in the neuronal stress response[@chen2023]:

• Oxidative stress protection — FANCF helps neurons cope with oxidative DNA damage
• Metabolic stress — The FA pathway is activated during metabolic challenges
• Neuroinflammation — FA pathway components modulate neuroinflammatory responses
• Synaptic function — DNA repair is crucial for synaptic plasticity

Therapeutic Targeting

Recent research highlights the potential for targeting the FA pathway in neurodegeneration[@yang2024]:

• FA pathway activators — Small molecules that enhance FA pathway function
• Synthetic lethality — Targeting FA-deficient neurons with specific agents
• Combination approaches — FA pathway modulation with other interventions
• Biomarker potential — FA pathway activity as a therapeutic biomarker

Expression and Regulation

Tissue Distribution

FANCF is ubiquitously expressed, with highest levels in:

• Bone marrow: Hematopoietic stem and progenitor cells
• Testis: High proliferative activity
• Ovary: Epithelial cells
• Brain: Neurons and glial cells

Regulation

FANCF expression is regulated at multiple levels:

• Transcriptional regulation: By p53 and other stress-responsive transcription factors
• Epigenetic regulation: Promoter methylation can silence FANCF expression
• Post-translational modification: Phosphorylation may regulate FANCF function

Therapeutic Implications

Cancer Therapy

FANCF represents a potential therapeutic target:

Chemosensitization: Tumors with low FANCF may be more sensitive to DNA crosslinking agents Synthetic Lethality: Inhibitors targeting tumors with FA pathway deficiency Biomarker: FANCF expression may predict chemotherapy response

Gene Therapy

Gene therapy approaches for FA-F are under development:

• Lentiviral vectors encoding FANCF
• CRISPR-based gene correction
• mRNA delivery of functional FANCF

Cross-References

• [FANCF Protein](/proteins/fancf-protein)
• [FANCD2 Gene](/genes/fancd2)
• [FANCA Gene](/genes/fanca)
• [FANCG Gene](/genes/fancg)
• [Fanconi Anemia Pathway](/mechanisms/fanconi-anemia-pathway)
• [DNA Repair Mechanisms](/mechanisms/dna-repair)
• [Interstrand Crosslink Repair](/mechanisms/interstrand-crosslink-repair)
• [Genomic Stability](/mechanisms/genomic-stability)

Protein Structure and Biochemical Properties

Domain Architecture

FANCF protein possesses a distinctive domain structure optimized for its scaffold function[@thompson2020][@joo2011]:

N-terminal Domain (1-150 aa):

• Contains binding sites for FANCA
• Multiple protein interaction motifs
• Flexible linker region

• Enables homodimer formation
• Creates stable scaffold platform
• Critical for function

• FANCG binding site
• Additional protein interactions
• Phosphorylation targets

Biochemical Properties

Physicochemical Properties:

• Molecular weight: ~42 kDa
• Isoelectric point: ~6.5
• Subcellular localization: nucleus, cytoplasm
• Post-translational modifications: phosphorylation, monoubiquitination

• FANCA: direct binding, stoichiometric interaction
• FANCG: C-terminal interaction
• FANCL: proximity for ubiquitination
• Other FA core complex members

Monoubiquitination

FANCF itself undergoes monoubiquitination, which is important for its function[@hodson2011]:

• FANCF is monoubiquitinated by FANCL
• Ubiquitination enhances scaffold function
• Required for efficient ICL repair
• Deubiquitination by USP1 regulates the cycle

FANCF in DNA Repair Mechanisms

Interstrand Crosslink Repair

The FA pathway, with FANCF as essential component, repairs ICLs through a coordinated mechanism:

Recognition Phase:

Activation Phase:

Repair Phase:

Coordination with Other Repair Pathways

FANCF and the FA pathway interact with other DNA repair mechanisms:

Nucleotide Excision Repair (NER):

• FA pathway cooperates with NER
• ICL unhooking requires NER proteins
• Sequential repair steps

• FA pathway activates HR repair
• FANCD1/BRCA2 functions in later stages
• RAD51 filament formation

• Polymerases Pol ζ, η, κ, ι involved
• FA pathway regulation of TLS
• Error-free vs error-prone TLS

Oxidative Stress Response

FANCF and ROS

FANCF plays a role in cellular response to oxidative stress[@yang2020]:

Oxidative DNA Damage:

• Reactive oxygen species cause various DNA lesions
• 8-oxoguanine is common lesion
• FA pathway repairs some oxidative damage

• Oxidative stress can induce FANCF expression
• p53 regulates FANCF under stress
• Cross-talk with antioxidant responses

• FA pathway activity protects against ROS
• Deficiency increases sensitivity to oxidants
• Links to age-related degeneration

Implications for Neurodegeneration

The oxidative stress-FANCF connection has implications for neurodegenerative diseases:

Alzheimer's Disease:

• Oxidative stress is a key feature
• FA pathway may be compromised
• Therapeutic potential of pathway activation

• Dopaminergic neurons are vulnerable to ROS
• FA pathway protects against oxidative damage
• Mitochondrial DNA repair important

Clinical Genetics

Fanconi Anemia Type F

FANCF mutations cause FA-F, a subtype of Fanconi anemia[@chistopolskiy2018]:

Inheritance:

• Autosomal recessive
• Both alleles must be mutated
• Compound heterozygotes common

• Congenital anomalies (variable)
• Bone marrow failure
• Cancer predisposition
• Cellular sensitivity to crosslinking agents

• Chromosome breakage assay (DEB, mitomycin C)
• FANCF sequencing
• Protein expression analysis

Genetic Testing

Testing Approaches:

• Targeted FANCF sequencing
• Multi-gene panels
• Whole exome sequencing
• Copy number analysis

• Heterozygote identification
• Prenatal testing
• Preimplantation genetic diagnosis

Gene Therapy Approaches

Viral Vector Delivery

Gene therapy for FANCF deficiency is being developed[@moreno2021]:

Vector Types:

• Lentiviral vectors (integration competent)
• AAV vectors (non-integrating)
• Self-inactivating vectors

• Ex vivo hematopoietic stem cell transduction
• In vivo delivery approaches
• Tissue-specific promoters

CRISPR-Based Therapies

Gene Correction:

• CRISPR/Cas9 nickase for precision editing
• Base editors for specific changes
• Prime editors for larger insertions

• Ex vivo correction and transplantation
• In vivo editing possibilities
• Allogeneic vs autologous approaches

FANCF in Neural Development

Brain Development

FANCF is expressed during neural development[@yang2021]:

Developmental Expression:

• Present in neural progenitor cells
• Regulated during differentiation
• Important for proliferation

• Maintains genomic stability in progenitors
• Protects against DNA damage during replication
• Ensures proper cell division

Implications for Neurodevelopmental Disorders

Dysregulation of FANCF may contribute to neurodevelopmental conditions:

• Some developmental disorders involve DNA repair
• Developmental brain abnormalities in FA patients
• Links to intellectual disability

Therapeutic Implications

Cancer Therapy

FANCF represents a therapeutic target in cancer:

Chemosensitization:

• Tumors with FA pathway deficiency
• Synthetic lethality approaches
• Combination with DNA damaging agents

• FANCF expression predicts response
• Methylation status as biomarker
• Patient selection for therapy

Neurodegeneration

FA pathway activation may benefit neurodegenerative diseases:

Therapeutic Strategies:

• Small molecule FA pathway activators
• Gene therapy approaches
• Antioxidant combinations

• FA pathway protects neurons
• DNA repair enhancement is beneficial
• Combination with other approaches

Research Directions and Future Perspectives

Unresolved Questions

Key questions remain about FANCF function:

Emerging Research

New research directions include:

• Single-cell analysis of FA pathway
• Structural studies of FANCF complexes
• Patient-derived models
• Gene therapy optimization

See Also

• [Genes Index](/genes)
• [Proteins Index](/proteins)
• [Mechanisms Index](/mechanisms)
• [DNA Repair Pathways](/mechanisms/dna-repair)
• [Fanconi Anemia](/diseases/fanconi-anemia)

External Links

• NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/2188](https://www.ncbi.nlm.nih.gov/gene/2188)
• OMIM: [https://omim.org/entry/607128](https://omim.org/entry/607128)
• Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163930](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163930)
• UniProt: [https://www.uniprot.org/uniprot/Q9NPI8](https://www.uniprot.org/uniprot/Q9NPI8)
• Fanconi Anemia Research Fund: [https://www.fanconi.org/](https://www.fanconi.org/)

References